What Myriad Genetics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 5 |
| Sells | 0 | 1 |
| Total trades | 4 | 63 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 257,731 | 3,074,213 |
| Disposed | 15,714 | 287,023 |
| Net activity | +242,017 | +2,787,190 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Wheeler Benjamin Richard | Chief Financial Officer | Sep 21 | Withheld — tax / exercise cost · F | −2,555 | $4.01 | −$10.2K | 287,193 |
| Sikri Vishal | EVP, Commercial | Sep 16 | Grant / award · A | +257,731 | — | — | 351,224 |
| Fox Jennifer Lynne | Chief Legal Officer | Sep 03 | Withheld — tax / exercise cost · F | −4,398 | $3.23 | −$14.2K | 305,964 |
| Wheeler Benjamin Richard | Chief Financial Officer | Aug 16 | Withheld — tax / exercise cost · F | −8,761 | $3.03 | −$26.5K | 289,748 |
| Donnelly Brian J | Chief Commerical Officer | Jun 11 | Grant / award · A | +5,000 | $3.94 | +$19.7K | 573,363 |
| Raha Samraat S. | President and CEO | Jun 11 | Grant / award · A | +3,542 | $3.94 | +$13.9K | 1,068,083 |
| Kumar Rashmi | Director | Jun 08 | Open-market sale · S | −15,000 | $4.46 | −$66.8K | 171,889 |
| Kumar Rashmi | Director | Jun 04 | Grant / award · A | +59,701 | — | — | 186,889 |
| Bisaro Paul | Director | Jun 04 | Grant / award · A | +59,701 | — | — | 157,142 |
| Reitan Colleen F | Director | Jun 04 | Grant / award · A | +59,701 | — | — | 152,030 |
| Dreismann Heiner | Director | Jun 04 | Grant / award · A | +59,701 | — | — | 231,145 |
| Phanstiel S. Louise | Director | Jun 04 | Grant / award · A | +59,701 | — | — | 341,652 |
| Newcomer Lee Nisley | Director | Jun 04 | Grant / award · A | +59,701 | — | — | 191,842 |
| Skovronsky Daniel | Director | Jun 04 | Grant / award · A | +59,701 | — | — | 195,507 |
| Davis Mark Steven | Director | Jun 04 | Grant / award · A | +59,701 | — | — | 106,665 |
| Jampa Raj | Chief Technology Officer | Jun 01 | Grant / award · A | +251,889 | — | — | 251,889 |
| Bisaro Paul | Director | May 14 | Open-market buy · P | +7,500 | $3.69 | +$27.6K | 97,441 |
| Donnelly Brian J | Chief Commerical Officer | May 01 | Withheld — tax / exercise cost · F | −55,975 | $4.80 | −$269K | 568,363 |
| Muzzey Dale | Chief Scientific Officer | Apr 14 | Withheld — tax / exercise cost · F | −946 | $4.91 | −$4.64K | 326,310 |
| Verratti Mark | Chief Operating Officer | Apr 14 | Withheld — tax / exercise cost · F | −1,069 | $4.91 | −$5.25K | 629,646 |
Loading...
